Current approaches against Alzheimer's disease in clinical trials

Journal of the Brazilian Chemical Society

Volumn 27, Issue 4, 2016, Pages 641-649

  Kuca, Kamil ^a,b   Soukup, Ondrej ^a,c   Maresova, Petra ^b,d   Korabecny, Jan ^a,c   Nepovimova, Eugenie ^a,e   Klimova, Blanka ^b   Honegr, Jan ^a,d   Ramalhob, Teodorico C ^b,f   Françab, Tanos C C ^b,g,h  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^b UNIVERSITY OF HRADEC KRALOVE   (Czech Republic)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^d UNIVERSITY OF OSTRAVA   (Czech Republic)

^e UNIVERSITY OF DEFENCE   (Czech Republic)

^f FEDERAL UNIVERSITY OF LAVRAS   (Brazil)

^g MILITARY INSTITUTE OF ENGINEERING   (Brazil)

^h Dept of Electrical and Computer Engineering   (Canada)

Author keywords

ABT 126; AC 42; Alzheimer's disease; Arecoline; Atorvastatin; Donepezil; Encenicline; Epigallocatechin gallate; Etazolate; Galantamine; Huperzine A; Immunotherapy; Methylene blue; Minocycline; Pioglitazone; Rivastigmine; Rosiglitazone; Semagacestat; Tacrine; Thalidomide; Tideglusib; Tramiprosate; Treatment; Valproic acid

Indexed keywords

EID: 84963808509     PISSN: 01035053     EISSN: 16784790     Source Type: Journal    
DOI: 10.5935/0103-5053.20160048     Document Type: Review

References (53)

1. World Health Organization (WHO); Dementia a Public Health Priority, 2012. Available at http://apps.who.int/iris/bitstream/10665/75263/1/9789241564458-eng.pdf accessed in January 2016.
2. Organization for Economic Co-operation and Development (OECD); Population Development, Historical Data and Forecast, 2015. Available at: http://stats.oecd.org/Index.aspx?DatasetCode=POP-FIVE-HIST accessed in February 2016.
3. Alzheimer's Disease International; The Global Impact of Dementia-An Analysis of Prevalence, Incidence, Cost and Trends; World Alzheimer Report, 2015. Available at: http://www.worldalzreport2015.org/downloads/worldalzheimerreport-2015-summary-sheet.pdf accessed in January 2016.
4. Maresova, P.; Mohelska, H.; Dolejs J.; Kuca K.; Curr. Alzheimer Res. 2015, 12, 903.
5. Klimova, B.; Maresova, P.; Valis, M.; Hort, J.; Kuca, K.; Clin. Interv. Aging 2015, 10, 1401.
6. Maresova, P.; Mohelska, H.; Kuca, K.; Procedia Economics and Finance 2015, 23, 534.
7. Ferri, C. P.; Prince, M.; Brayne, C.; Brodaty, H.; Fratiglioni, L.; Ganguli, M.; Hall, K.; Hasegawa, K.; Hendrie, H.; Huang, Y.; Jorm, A.; Mathers, C.; Menezes, P. R.; Rimmer, E.; Scazufca, M.; Lancet 2005, 366, 2112.
8. Ballard, C.; Gauthier, S.; Corbett, A.; Brayne, C.; Aarsland, D.; Jones, E.; Lancet 2011, 377, 1019.
9. Blennow, K.; De Leon, M. J.; Zetterberg, H.; Lancet 2006, 368, 387.
10. Zemek, F.; Drtinova, L.; Nepovimova, E.; Sepsova, V.; Korabecny, J.; Klimes, J.; Kuca, K.; Expert Opin. Drug Saf. 2014, 13, 759.
11. Bartus, R. T.; Dean, R. L.; Beer, B.; Lippa, A. S.; Science 1982, 217, 408.
12. Francis, P. T.; Palmer, A. M.; Snape, M.; Wilcock, G. K.; J. Neurol., Neurosurg. Psychiatry 1999, 66, 137.
13. Pákáski, M.; Kálmán, J.; Neurochem. Int. 2008, 53, 103.
14. Tagami, S.; Tsujimoto, Y.; Akaike, A.; Takashima, A.; Hasegawa, M.; Ishiguro, K.; Shoji, M.; Ito, N.; Kanemaru, K.; Urakami, K.; Okochi, M.; Takeda, M.; Psychogeriatrics 2006, 6, S57.
15. Nordberg, A.; Svensson, A. L.; Drug Saf. Int. J. Med. Toxicol. Drug Exp. 1998, 19, 465.
16. Qian, Z. M.; Ke, Y.; Front. Aging Neurosci. 2014, 6, 216.
17. Avery, E. E.; Baker, L. D.; Asthana, S.; Drugs Aging 1997, 11, 450.
18. Greig, N. H.; Reale, M.; Tata, A. M.; Recent Pat. CNS Drug Discovery 2013, 8, 123.
19. Berman, H. M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T. N.; Weissig, H.; Shindyalov, I. N.; Bourne, P. E.; Nucleic Acids Res. 2000, 28, 235.
20. Nickols, H. H.; Conn, P. J.; Neurobiol. Dis. 2014, 61, 55.
21. Russo, P.; Del Bufalo, A.; Frustaci, A.; Fini, M.; Cesario, A.; Curr. Pharm. Des. 2014, 20, 6014.
22. Deardorff, W. J.; Shobassy, A.; Grossberg, G. T.; Expert Rev. Neurother. 2015, 15, 7.
23. Mazurov, A.; Yohannes, D.; Top. Med. Chem. 2015, 13, 213.
24. Beinat, C.; Banister, S. D.; Herrera, M.; Law, V.; Kassiou, M.; CNS Drugs 2015, 29, 529.
25. Spencer, T.; Biederman, J.; J. Atten. Disord. 2002, 6, S109.
26. Hardy, J.; J. Neurochem. 2009, 110, 1129.
27. Maltsev, A. V.; Bystryak, S.; Galzitskaya, O. V.; Ageing Res. Rev. 2011, 10, 440.
28. Verdile, G.; Fuller, S.; Atwood, C. S.; Laws, S. M.; Gandy, S. E.; Martins, R. N.; Pharmacol. Res. 2004, 50, 397.
29. Walsh, D. M.; Selkoe, D. J.; J. Neurochem. 2007, 101, 1172.
30. Yan, R.; Vassar, R.; Lancet Neurol. 2014, 13, 319.
31. Cheng, H.; Shang, Y.; Jiang, L.; Shi, T.-L.; Wang, L.; Int. J. Neurosci., in press, DOI: 10.3109/00207454.2015.1015722.
32. Mendes, D.; Alves, C.; Batel-Marques, F.; Pharmacoepidemiol. Drug Saf. 2015, 24, 1259.
33. Chen, X.; Hui, L.; Geiger, J. D.; J. Neurol. Neurophysiol. 2014, 5, 236.
34. McGuinness, B.; Craig, D.; Bullock, R.; Malouf, R.; Passmore, P.; Cochrane Database Syst. Rev. 2014, 7, CD007514.
35. He, P.; Cheng, X.; Staufenbiel, M.; Li, R.; Shen, Y.; PloS One 2013, 8, e55091.
36. Ferretti, M. T.; Allard, S.; Partridge, V.; Ducatenzeiler, A.; Cuello, A. C.; J. Neuroinflammation 2012, 9, 62.
37. Henley, D. B.; Sundell, K. L.; Sethuraman, G.; Dowsett, S. A.; May, P. C.; Curr. Med. Res. Opin. 2014, 30, 2021.
38. De Strooper, B.; Vassar, R.; Golde, T.; Nat. Rev. Neurol. 2010, 6, 99.
39. Vellas, B.; Sol, O.; Snyder, P. J.; Ousset, P.-J.; Haddad, R.; Maurin, M.; Lemarié, J.-C.; Désiré, L.; Pando, M. P.; Curr. Alzheimer Res. 2011, 8, 203.
40. Caltagirone, C.; Ferrannini, L.; Marchionni, N.; Nappi, G.; Scapagnini, G.; Trabucchi, M.; Aging: Clin. Exp. Res. 2012, 24, 580.
41. Aisen, P. S.; Gauthier, S.; Ferris, S. H.; Saumier, D.; Haine, D.; Garceau, D.; Duong, A.; Suhy, J.; Oh, J.; Lau, W. C.; Sampalis, J.; Arch. Med. Sci. 2011, 7, 102.
42. Chang, X.; Rong, C.; Chen, Y.; Yang, C.; Hu, Q.; Mo, Y.; Zhang, C.; Gu, X.; Zhang, L.; He, W.; Cheng, S.; Hou, X.; Su, R.; Liu, S.; Dun, W.; Wang, Q.; Fang, S.; Exp. Cell Res. 2015, 334, 136.
43. Medeiros, R.; Baglietto-Vargas, D.; LaFerla, F. M.; CNS Neurosci. Ther. 2011, 17, 514.
44. Avila, J.; Santa-María, I.; Pérez, M.; Hernández, F.; Moreno, F.; J. Biomed. Biotechnol. 2006, 2006, 74539.
45. Hooper, C.; Killick, R.; Lovestone, S. T.; J. Neurochem. 2008, 104, 1433.
46. Martinez, A.; Gil, C.; Perez, D. I.; Int. J. Alzheimer's Dis. 2011, 2011, 280502.
47. Lovestone, S.; Boada, M.; Dubois, B.; Hüll, M.; Rinne, J. O.; Huppertz, H.-J.; Calero, M.; Andrés, M. V.; Gómez-Carrillo, B.; León, T.; Del Ser, T.; J. Alzheimer's Dis. 2015, 45, 75.
48. Oz, M.; Lorke, D. E.; Petroianu, G. A.; Biochem. Pharmacol. 2009, 78, 927.
49. Wischik, C. M.; Staff, R. T.; Wischik, D. J.; Bentham, P.; Murray, A. D.; Storey, J. M. D.; Kook, K. A.; Harrington, C. R.; J. Alzheimer's Dis. 2015, 44, 705.
50. Agadjanyan, M. G.; Petrovsky, N.; Ghochikyan, A.; Alzheimer's Dementia 2015, 11, 1246.
51. Delrieu, J.; Ousset, P. J.; Voisin, T.; Vellas, B.; Rev. Neurol. 2014, 170, 739.
52. Kontsekova, E.; Zilka, N.; Kovacech, B.; Novak, P.; Novak, M.; Alzheimer's Res. Ther. 2014, 6, 44.
53. Cavalli, A.; Bolognesi, M. L.; Minarini, A.; Rosini, M.; Tumiatti, V.; Recanatini, M.; Melchiorre, C.; J. Med. Chem. 2008, 51, 347.